Japan Safety Biomarker Workshop

February 10, 2017

On February 20-21, 2017, the Critical Path Institute's Predictive Safety Testing Consortium (PSTC), the RIKEN Institute, National Institute of Health Sciences, Japan Pharmaceutical Manufacturers' Association, and the Japan Society of Toxicology will collaboratively hold the Japan Safety Biomarker Workshop at the RIKEN Institute, in Yokohama, Japan.

This two-day conference assembles leading scientists and researchers from industry and academia, and government regulatory authorities, and provides a unique opportunity to gain perspective on biomarker development and application of biomarkers in preclinical and clinical research. Topics to be covered include an overview of biomarkers in drug development, application of biomarkers in clinical use, and biomarker qualification.

The objective of the conference is to engage scientific and regulatory scientists in Japan for the qualification of biomarkers. The conference format is designed to elicit participant feedback on biomarker qualification and identify areas for synergy across the pharmaceutical industry and academia.

PSTC is a unique, public-private partnership that brings pharmaceutical companies together to share, validate, and qualify safety testing methods under the advisement of worldwide regulatory agencies, including the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the PMDA.

PSTC's primary goal is the qualification of novel translational safety biomarkers for use in early clinical drug development trials.
-end-


The Critical Path Institute (C-Path)

Related Biomarkers Articles from Brightsurf:

Urgent need for blood-based biomarkers to diagnosis concussion
There is an urgent need for objective markers for diagnosing concussion, or mild traumatic brain injury.

Engineered bacteria churn out cancer biomarkers
A Cornell lab has created these very tools by commandeering simple, single-celled microorganisms - namely E. coli bacteria - and engineering them to explore the complex process of glycosylation and the functional role that protein-linked glycans play in health and disease.

Exercise induces secretion of biomarkers into sweat
The aim was to reveal the potential of microRNAs in sweat extracellular vesicles in monitoring exercise performance.

Phosphoprotein biomarkers to guide cancer therapy are identified
Researchers led by James Bibb, Ph.D., professor of surgery at the University of Alabama at Birmingham, suggest using a broader lens of post-translational modification analysis to identify new biomarkers of cancer drivers that may allow a much more precise prediction of patient responses to treatments.

Exhaled biomarkers can reveal lung disease
Using specialized nanoparticles, MIT engineers have developed a way to diagnose pneumonia or other lung diseases by analyzing the breath exhaled by the patient.

Race-specific lupus nephritis biomarkers
A University of Houston biomedical researcher has discovered a difference in urinary biomarker proteins of lupus nephritis in patients according to race.

Semen miRNAs could be non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr.

Scientists have found longevity biomarkers
An international group of scientists studied the effects of 17 different lifespan-extending interventions on gene activity in mice and discovered genetic biomarkers of longevity.

After concussion, biomarkers in the blood may help predict recovery time
A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

3D-printed device detects biomarkers of preterm birth
Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy.

Read More: Biomarkers News and Biomarkers Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.